SSO would like to thank the following companies for their support. Please select a name to learn more.
The Appendix Cancer PMP (ACPMP) Research Foundation is dedicated to:
- Funding and supporting research to discover new treatments for appendix cancer with the hope of finding a cure for all.
- Funding and supporting educational programs for health care professionals, patients, and caregivers & families to keep current with the evolving science and to increase awareness about this rare cancer.
Visit https://acpmp.org to learn more.
Beeken Biomedical® is passionate about finding solutions to improve patient outcomes for blood loss. We have developed a variety of NuStat® hemostatic wound dressings to control bleeding in public safety, wound care, surgery, and more. Our NuStat® product portfolio, featuring Hemafiber®, requires no preparation, is durable, soft & pliable, absorbent, and controls bleeding rapidly.
GE HealthCare’s Pharmaceutical Diagnostics is a global leader in imaging agents. Its MI portfolio combines products across cardiology, neurology, and oncology, with a R&D pipeline, all aimed at enabling better-informed diagnosis and monitoring for improved clinical outcomes.
Intera Oncology® Inc. is a Boston-based medical device company founded in 2019 by two doctors with a singular vision for improving the survival of colorectal cancer and cholangiocarcinoma patients by ensuring access to Hepatic Artery Infusion (HAI) therapy. Dedicated to helping patients live longer and better lives, Intera Oncology manufactures the only FDA-approved pump for HAI therapy – the Intera 3000 Hepatic Artery Infusion Pump.
In 1985, the Wayne family created the John Wayne Cancer Foundation (JWCF) to honor John Wayne’s wish to use his name to help fight cancer. John Wayne won his battle with lung cancer. Then 15 years later, lost the battle to stomach cancer in 1979.
The Foundation’s mission is to lead the fight against cancer with courage, strength, and grit. JWCF funds novel and innovative programs that improve cancer patients’ outcomes and save lives through research, education, awareness, and support.
As many of us know, the John Wayne Cancer Foundation established the John Wayne Cancer Foundation Surgical Oncology Fellowship Program many years ago and continues to train top surgeons at the University of California, Irvine. This program has not only trained renown Surgical Oncologists; but also leads to groundbreaking research and treatments, including the Sentinel Node Biopsy.
Bold thinking. Bolder actions. We are Medtronic.
We lead global healthcare technology and boldly attack the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 90,000+ passionate people. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world.
In everything we do, we are engineering the extraordinary.
PMP Pals is the world’s oldest, global, volunteer-run peer-to-peer support community for patients and caregivers living with Appendix Cancer, Pseudomyxoma Peritonei (PMP) and related peritoneal surface malignancies. PMP Pals supports patients and caregivers in a personal and direct way and builds emotional resilience by sharing our hope, experience, resources and information with each other through programs and services that meet the challenges of this rare disease.
REGER is a pioneer in the development and production of state-of-the-art Nebulizer systems for use in intraperitoneal application.
REGER’s first Nebulizer was developed in 2009 and laid the foundation for innovation in this specialised field.
Since 2012, the company’s Nebulizer system has been considered the Gold Standard for the precise and reliable distribution of substances within the abdominal cavity.
In 2023, REGER continued its history of innovation with the introduction of the QuattroJet. This next-generation Nebulizer is equipped with four nozzles that enable optimized distribution. The products are approved for the US and European markets.
REGER’s Nebulizers are used by healthcare professionals worldwide and are backed by extensive clinical research.
With a clear focus on quality and continuous development, the company remains a leader in providing advanced solutions for intraperitoneal applications.
Replimune Group, Inc., headquartered in Woburn, MA, was founded in 2015 with the mission to transform cancer treatment by pioneering the development of a novel portfolio of oncolytic immunotherapies. Replimune’s proprietary RPx platform is based on a potent HSV-1 backbone intended to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The RPx platform is designed to have a unique dual local and systemic activity consisting of direct selective virus-mediated killing of the tumor resulting in the release of tumor derived antigens and altering of the tumor microenvironment to ignite a strong and durable systemic response. The RPx product candidates are expected to be synergistic with most established and experimental cancer treatment modalities, leading to the versatility to be developed alone or combined with a variety of other treatment options. For more information, please visit www.replimune.com.
SpringWorks is a commercial-stage biopharmaceutical company applying a precision medicine approach to developing and delivering life-changing medicines for people with severe rare diseases and cancer. SpringWorks also has a diversified targeted therapy pipeline spanning solid tumors and hematological cancers, with programs ranging from preclinical development through advanced clinical trials. In addition to its wholly owned programs, SpringWorks has also entered into multiple collaborations with innovators in industry and academia to unlock the full potential for its portfolio and create more solutions for patients in need.
ThermaSolutions is the international leader in providing the ThermoChem HT family of systems and customized disposables.
We support Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and laparoscopic aerosolization programs worldwide.